Aug 4, 2026 04:01PM
Jul 21, 2026 06:12AM
May 13, 2026 07:17AM
May 13, 2026 07:11AM
May 6, 2026 08:00AM
Mar 12, 2026 08:00AM
Nov 12, 2025 07:09AM Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 4c
Nov 12, 2025 07:01AM
Aug 12, 2025 07:05AM
May 14, 2025 04:26PM
May 14, 2025 07:04AM
Mar 13, 2025 04:38PM
Mar 13, 2025 07:08AM
Nov 12, 2024 05:20PM Milestone Pharmaceuticals Inc. (MIST) Tops Q3 EPS by 2c
Nov 12, 2024 09:03AM
Oct 14, 2024 07:23AM
Aug 9, 2024 06:26AM
Aug 8, 2024 04:17PM
Jul 2, 2024 06:41AM
May 13, 2024 07:15AM
Mar 21, 2024 07:14AM Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update
Nov 13, 2023 07:05AM
Nov 13, 2023 06:58AM
Nov 13, 2023 06:57AM
Aug 10, 2023 07:35AM
May 11, 2023 07:16AM
Mar 29, 2023 09:17AM
Nov 10, 2022 07:21AM Milestone Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Corporate Update
Aug 10, 2022 04:15PM
May 12, 2022 07:15AM
Mar 24, 2022 07:20AM
Mar 24, 2022 07:20AM
Nov 12, 2021 07:20AM
Aug 11, 2021 04:18PM
May 17, 2021 07:01AM Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update
Mar 29, 2021 05:32PM
Nov 13, 2020 07:00AM
Aug 12, 2020 07:00AM
May 14, 2020 07:15AM
Mar 6, 2020 07:00AM
Nov 13, 2019 07:00AM
Aug 13, 2019 07:00AM Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results

1,213,653 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All